Weight-loss medicines such as Ozempic might raise a person’s likelihood of developing conditions including arthritis.

While weight-loss drugs were linked to lower risk of some conditions, they were also associated with some adverse health ...

Novo Nordisk said on Friday a late-stage trial with a high-dose version of its weight loss drug semaglutide helped overweight ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.

An international commission made the case for focusing on body fat quantity and the illnesses people experience.

The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...

New recommendations on how to define obesity would reduce the emphasis on body mass index and also take into account health ...

Diabetes and weight loss drugs Ozempic and Wegovy have been added to the list of medications selected for Medicare price ...

The governor also said she would work with other states to leverage their combined purchasing power to reduce the cost of the ...

Can weight loss drugs curb alcohol addictions? This Louisiana doctor is keeping an eye on new findings and emerging research.